MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, XLO has $163,487K in assets. $90,942K in debts. $150,333K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
358.95%
Quick Ratio
358.95%
Cash Ratio
349.94%
Debt to Asset Ratio
55.63%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, current portio...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
150,333 137,531 103,764 121,551
License agreement receivable
--17,500 -
Collaboration and license agreement receivable
0 5,000 --
Prepaid expenses and other current assets
3,874 2,496 2,825 2,165
Total current assets
154,207 145,027 124,089 123,716
Restricted cash
1,813 1,807 1,801 1,794
Property and equipment
12,777 12,645 12,139 -
Less accumulated depreciation
9,097 8,753 8,460 -
Property and equipment, net
3,680 3,892 3,679 4,018
Operating lease right-of-use asset
3,787 3,959 4,125 4,285
Total assets
163,487 154,685 133,694 133,813
Accounts payable
1,064 3,168 2,300 4,097
Accrued expenses
8,970 11,739 8,952 5,621
Deferred revenue, current portion
31,542 40,023 43,846 42,278
Operating lease liability, current portion
1,384 1,343 1,303 1,264
Total current liabilities
42,960 56,273 56,401 53,260
Deferred revenue, net of current portion
16,468 20,635 25,498 28,632
Operating lease liability, net of current portion
5,254 5,611 5,960 6,302
Common stock warrant liabilities
26,260 29,560 53,930 38,550
Liabilities to issue common stock
-7,333 --
Total liabilities
90,942 119,412 141,789 126,744
Common stock, 0.0001 par value 600,000,000 shares authorized 5,782,536 shares issued and outstanding at march 31, 2026 4,530,641 shares issued and outstanding at december 31, 2025
1 -5 5
Additional paid-in capital
500,862 454,062 421,049 419,926
Accumulated deficit
-428,318 -418,789 -429,149 -412,862
Total stockholders' equity
72,545 35,273 -8,095 7,069
Total liabilities and stockholders' equity
163,487 154,685 133,694 133,813
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$150,333K Prepaid expenses andother current assets$3,874K Property and equipment$12,777K Total current assets$154,207K Operating leaseright-of-use asset$3,787K Property and equipment,net$3,680K Restricted cash$1,813K Less accumulateddepreciation$9,097K Total assets$163,487K Total liabilities andstockholders' equity$163,487K Total liabilities$90,942K Total stockholders'equity$72,545K Accumulated deficit-$428,318K Total currentliabilities$42,960K Common stock warrantliabilities$26,260K Deferred revenue, net ofcurrent portion$16,468K Operating leaseliability, net of current...$5,254K Additional paid-in capital$500,862K Common stock, 0.0001par value...$1K Deferred revenue,current portion$31,542K Accrued expenses$8,970K Operating leaseliability, current portion$1,384K Accounts payable$1,064K

Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics, Inc. (XLO)